1. 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. (10th December 2020) Authors: Melero, Ignacio; Gomez-Roca, Carlos; Ferre, Pierre; Ferre, Pierre; Chetaille, Eric; Petain, Aurelie; Thuilliez, Celine; Vandenberghe, Isabelle; Cruzalegui, Francisco; Boudribila, Asmaa; Pavlyuk, Mariya; Marabelle, Aurelien Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody. (9th November 2020) Authors: Melero, Ignacio; Gomez-Roca, Carlos; Ferre, Pierre; Ferre, Pierre; Chetaille, Eric; Petain, Aurelie; Thuilliez, Celine; Vandenberghe, Isabelle; Cruzalegui, Francisco; Boudribila, Asmaa; Pavlyuk, Mariya; Marabelle, Aurelien Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ferrous sulfate oral solution in young children with iron deficiency anemia: An open‐label trial of efficacy, safety, and acceptability. Issue 7 (9th July 2020) Authors: Pachuta Węgier, Lidia; Kubiak, Maciej; Liebert, Agata; Clavel, Thierry; Montagne, Agnès; Stennevin, Aline; Roye, Sandrine; Boudribila, Asmaa Journal: Pediatrics international Issue: Volume 62:Issue 7(2020) Page Start: 820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗